Abstract Title:

Acute cholestatic hepatitis induced by fenofibrate.

Abstract Source:

J Clin Pharm Ther. 2009 Oct;34(5):599-602. PMID: 19744016

Abstract Author(s):

D Hajdu, K Aiglová, I Vinklerová, K Urbánek

Article Affiliation:

Department of Pharmacology, Faculty of Medicine and Dentistry of Palacky University and University Hospital, Olomouc, Czech Republic.

Abstract:

We report a case of acute liver injury probably due to fenofibrate. A 50-year-old female without a history of liver disease developed cholestatic hepatitis during her second week of fenofibrate treatment. Laboratory tests on admission showed serum bilirubin 534.0 mcmol/L (conjugated 444.0), alkaline phosphatase (AP) 8.76, gamma-glutamyl traspeptidase (GGT) 20.92, alanine aminotransferase (ALT) 2.6, aspartate aminotransferase (AST) 3.64 mckat/L. Fenofibrate withdrawal and ursodeoxycholic acid (750 mg daily) administration was rapidly followed by a favourable outcome.

Study Type : Human: Case Report

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.